Clinical Trial Update: Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial exploring concurrent neoadjuvant chemotherapy and endocrine therapy for HER2-positive breast cancer; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Legacy Health System | Conditions: Breast Cancer - Infiltrating Ductal Carcinoma, HER-2 Positive Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING